Stella Hahn
Hofstra University
13 Papers
46 Citations
Stella Hahn is an academic researcher from Hofstra University. The author has contributed to research in topics: Medicine & Intensive care. The author has an hindex of 4, co-authored 11 publications. Previous affiliations of Stella Hahn include Long Island Jewish Medical Center & North Shore University Hospital.
Chat about Author
Papers
Validation of a Host Response Assay, SeptiCyte LAB, for Discriminating Sepsis from Systemic Inflammatory Response Syndrome in the ICU.
Russell R. Miller,Russell R. Miller,Bert K. Lopansri,Bert K. Lopansri,John P. Burke,John P. Burke,Mitchell M. Levy,Steven M. Opal,Richard E. Rothman,Franco R. D'Alessio,Venkataramana K. Sidhaye,Neil R. Aggarwal,Robert A. Balk,Jared A. Greenberg,Mark Yoder,Gourang P. Patel,Emily R. Gilbert,Majid Afshar,Jorge P. Parada,Greg S. Martin,Annette M. Esper,Jordan A. Kempker,Mangala Narasimhan,Adey Tsegaye,Stella Hahn,Paul H. Mayo,Tom van der Poll,Marcus J. Schultz,Brendon P. Scicluna,Peter M. C. Klein Klouwenberg,Antony Rapisarda,Therese Seldon,Leo McHugh,Thomas D. Yager,Silvia Cermelli,Dayle Sampson,Victoria Rothwell,Richard Newman,Shruti Bhide,Brian A. Fox,James T. Kirk,Krupa Arun Navalkar,Roy F. Davis,Roslyn A. Brandon,Richard Bruce Brandon +44 more
TL;DR: SeptiCyte LAB appears to be a promising diagnostic tool to complement physician assessment of infection likelihood in critically ill adult patients with systemic inflammation.
Pneumothorax in COVID-19 Acute Respiratory Distress Syndrome: Case Series
Kelvin Wong,Kelvin Wong,Dae Hyeon Kim,Dae Hyeon Kim,Annamaria Iakovou,Annamaria Iakovou,Sameer Khanijo,Sameer Khanijo,Sameer Khanijo,Adey Tsegaye,Adey Tsegaye,Stella Hahn,Stella Hahn,Mangala Narasimhan,Mangala Narasimhan,Gulrukh Zaidi,Gulrukh Zaidi +16 more
TL;DR: Despite overall adherence to best practice ventilator management in ARDS, a large number of pneumothoraces were observed during the COVID-19 pandemic, with significant factors in the conservatively managed group included lack of tension physiology, the smaller size of pneumothsorax, lack of underlying diabetes, presence of pneumomediastinum, and not being on mechanical ventilation during diagnosis.
Effective use of monoclonal antibodies for treatment of persistent COVID-19 infection in a patient on rituximab.
TL;DR: In this paper, a case of monoclonal antibody use after 54 days of symptom onset in an immunosuppressed patient with persistent COVID-19 infection despite standard treatment was presented.
19
A review of therapeutic agents for the management of pulmonary arterial hypertension.
TL;DR: This article reviews the agents currently available for the medical management of PAH and describes the currently available therapies for treating pulmonary arterial hypertension.
14
Early in-hospital clinical deterioration is not predicted by severity of illness, functional status, or comorbidity
TL;DR: It is suggested that it is difficult to predict early clinical deterioration as none of the measured parameters were associated with RRT activation.